Enquiry 7069001001
Book a Video Consultation
Book An Appointment
Emergency Number
Book Homecare Services

Shalby Limited (NSE: SHALBY) and Stock Exchange Information (BSE: 540797) is India’s leading multi-specialty hospital operating a chain of 11 tertiary hospitals with an aggregate bed capacity of over 2,000 hospital beds. It is one of the top hospitals in joint replacement surgery in India. Shalby is the number one player worldwide for knee replacement surgery and has a 4,000 plus in-house team of skilled doctors, surgeons and support staff. The objective of the Investor Relation Website is to ensure continuous and open communication with its shareholders and all financial market participants.

Registered Office
Name Shalby Limited
Address Opp. Karnawati Club,Sarkhej Gandhinagar Highway,Near Prahlad Nagar Garden,Ahmedabad – 380 015, Gujarat, India
Phone  +91 79 4020 3000
Fax +91 79 4020 3120
CIN L85110GJ2004PLC044667
Grievance Redressal & Nodal Officer
Name Mr. Tushar Shah (Associate Vice President and Company Secretary)
Email Companysecretary@shalby.in
Phone +91 79 4020 3000 / +91 79 40203296
Investor Relations
Name Mr. Puneet Maheshwari
Email ircs3.corp@shalby.org
Phone +91 9512049071

Annual Reports
2016-17 2017-18 2018-19 2019-20 2020-21 2021-22
Shalby Limited
Subsidiary Companies
Shalby (Kenya) Limited
Yogeshwar Healthcare Ltd.
Vrundavan Shalby Hospitals Ltd.
Shalby International Ltd.
Griffin Mediquip LLP
Slaney Healthcare
Mars Medical Devices
Shalby Hospital Mumbai Pvt Limited
Annual Return
FY 2017-18
FY 2018-19
FY 2019-20
FY 2020-21
FY 2021-22
Financial Year Q1 Q2 Q3 Q4
2017-18
2018-19
2019-20
2020-21
2021-22
2022-23

 

Financial Year Q1 Q2 Q3 Q4
2017-18
2018-19
2019-20
2020-21
2021-22
2022-23

 

Investor Presentation June-21

Financial Year Q1 Q2 Q3 Q4
2018-19
2019-20
2020-21
2021-22
2022-23

 

Financial Year Q1 Q2 Q3 Q4
2020-21
2021-22
2022-23
Financial Year Q1 Q2 Q3 Q4
2017-18  
2018-19
2019-20
2020-21
2021-22
2022-23

Statement of Investor Complaints – Q4 FY 2017-18
Share Capital Audit – 31-03-2018
Compliance Certificate under Reg. 7(3) of LODR
Press Release – MoU with Sen Sok Intl Hospital, Cambodia
Certificate under Regulation 40(10) of SEBI LODR
Joint Replacement Surgeries under Mukhyamantri Amrutam Yojana
Change in CIN
Schedule of Investor / Analyst Meet
Schedule of Investor / Analyst Meet – 27-04-2018
Intimation Conference Call
Intimation Appointment of CDSL as designated depository
Collaboration with Berkeley Health Education
Investor/Analyst meeting with Motilal Oswal Securities Limited
Investors meet/UBS India- Midcap conference
Resignation of Chief Executive Officer of the Company
Intimation Analyst meet HDFC Securities 26-06-2018
Updates relating to resignation of CEO
Man of the Year Award – Dr. Vikram Shah
Intimation Analyst meet – 26-06-2018
Intimation Analyst meet - 27-06-2018
Intimation Analyst meet - 02-07-2018
Intimation Analyst meet – 06-07-2018
Intimation Liver Disease and Transplantation
Karvy Reconciliation Report
Investor Grievance report
 Intimation of AGM
 Intimation of Book closure
 AGM Notice & Annual Report 2017-18
 Newspaper Ad. AGM, Book closure & E-voting
 Outcome of AGM
 Voting Results
 Shalby Press Release - Ovarian Mass Removal Jaipur
 Credit Rating ICRA Reg 30 LODR
 Reg 30 Orthotrends 2018 Chandigarh
 Intimation under Regulation 30 of SEBI LODR-concall with Edelweiss
 Investor Grievance Report Q2 FY 2018-19
 Share Capital Audit Q2 FY 2018-19
 Compliance Certificate 7(3) – 30-09-2018
 Certificate under Regulation 40(10) of SEBI LODR –H1 FY 2018-19
 Pre Accreditation Entry level NABH at Shalby Surat
 Intimation for Conference call
 Submission of newspaper AD – Notice of Board Meeting
 Pre-Accreditation Entry level NABH at Shalby Naroda
 Newspaper ad for Issue of Duplicate Shares
 Intimation Analyst Meet – Nalanda Capital
 Intimation participation in IDFC Investor Conference
 Investor conference Kotak
 Intimation Issue of Duplicate Shares
 Press Release Kolkata
 Intimation Transfer of operations Karvy
 Medical Value Travel Specialist Hospital Award 2018
 Best hospital for Medical Tourism in Gujarat Award
 Share Capital Audit Q3 FY 2018-19
  Intimation of Investor Analyst Concall
Intimation of Conference Call
Intimation Analyst meet - DSP BlackRock Investment
 Newspaper ad for Q3 FY 2018-19 Results

Intimation of Trading Window Closure
Compliance Certificate 7(3)-31-03-2019
 Intimation Of Analyst Meet
 Certificate under Regulation 40(10) of SEBI LODR –H2 FY 2018-19
 Reconciliation of Share Capital Q4 2018-19
 Interaction with electronic media
 Recommendation of Dividend for FY 2018-19
 Schedule of Investor / Analyst Meet Q4 FY19
 Submission of newspaper ad results Q4 FY2018-19
 Disclosure under SEBI PIT Reg. 7(2) 30.05.2019
 Disclosure under SEBI PIT Reg. 7(2) 01.06.2019
 Intimation of Trading Window Closure
 Best IT enabled Hospital Award
 Reconciliation of Share Capital Q1 2019-20
 Certificate under Regulation 74 (5) Q1 2019-20
 Schedule of Investor Conference Call Q1 FY19
 News Paper Advertisement PAS-1 AGM
 Participation in Emkay Confluence at Mumbai – 08-Aug-2019
 Participation in Elara Annual Conference at Mumbai-– 05-September-2019
 Gujarat HealthCare Leadership Award 2019
 Intimation of Trading Window closure – Q2 FY 2019-20 Fin. Results
 Dare to Dream -Zee Business Award - Company of the Year
 Credit Rating ICRA Reg 30 LODR
 Certificate under Regulation 40(10) of SEBI LODR –H1 FY 2019-20
 Clarification Of Price Movement
 Investor Con-call Q2 FY2019-20
 Press Release- Q2FY20 Financial Results
 Submission of newspaper ad results Q2 FY2019-20
 Change of name of Registrar & Transfer Agent
Intimation of Trading Window closure – Q3 FY 2019-20 Fin. Results
 Compliance Certificate Q3 30-09-2019
 Reconciliation of Share Capital Audit Report Q3 FY 2019-20
 Change in Details of RTA
 Investor Con-call Q3 FY2019-20
 Clarification as to increase in volume of shares
 Re-appointment of CMD
 Submission of newspaper ad results Q3 FY2019-20
 Disclosure under SEBI PIT Reg. 7(2) 26.02.2020

 Intimation Of Subsidiary Company
 Con-call with Investors to address general queries about ongoing COVID-19 pandamic
 Con-call with Investors hosted by HDFS Sec to address general queries about ongoing COVID-19 pandemic
 Clarification Of Price MOvement To NSE
 Clarification Of Price MOvement To BSE
 Intimation of Testing of COVID-19 cases at Indore Shalby Hospital
 Con-call intimation hosted by Edelweiss
 Con-call intimation hosted by Edelweiss
  Compliance Certificate 7(3) – 31-03-2020
  Certificate under Reg.74(5) of SEBI (DP) Regulations, 2018
  Treatment of Covid-19 Patient at Shalby Hospital
 Conference call hosted by Centrum Broking Ltd.
 Certificate under Regulation 40(10) of SEBI LODR –H1 FY 2019-20
 Reconciliation of Share Capital Audit Report Q4 FY 2019-20
 Disclosure as to Large Corporate
 Schedule of Investor / Analyst Meet Q4 FY20
 Trading Window Closure Notice For Q1 FY2021
 Intimation of Treatment of Covid-19 Patient at Shalby Hospital, Surat
 Intimation of Treatment of Covid-19 Patient at Shalby Hospital, Vapi
 Credit Rating ICRA Reg 30 LODR
  Certificate under Regulation 74 (5) Q1 2020-21
  Disclosure of impact of CoVID-19 on the business and operations
 Reconciliation of Share Capital Audit Report Q1 FY 2020-21
 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome”
 Announcement under Secretarial Compliance Report FY 2019-20”
 Aquisition Subsidiaries
 Investor Call Intimation
 Submission of newspaper ad for results Q1 FY2020-21
 Notice of 16th Annual General Meeting
 Intimation of Board of Directors Meeting
 Outcome of Board meeting
 Compliance Certificate 7(3) – 30-09-2020
 Certificate under Regulation 74 (5) Q2 2020-21
 Investor Conference Call Q2 F.Y. 2020-21
 Newspaper Ad for Results Q2 FY 2020-21
 Certificate under Regulation 40(10) of SEBI LODR –H1 FY 2020-21
 Reconciliation of Share Capital Audit Report Q2 FY 2020-21
 Investor Analyst Call
 Intimation Of Subsidiary Company SHMPL
 Intimation Of Subsidiary Company SHMPL
 Certificate under Regulation 74 (5) Q3 2020-21
 Schedule of Investor / Analyst Meet Q3 FY2021
 Shalby Limited Q3 FY2021 Press Release
 Reconciliation of Share Capital Audit Report Q3 FY 2020-21
 Investor / Analyst Meet
Change in Company Secretary & Compliance Officer
Disclosure under Regulation 30 (5) of the SEBl - LODR
Annual Secretarial Compliance Report FY2021
Reconciliation of Share Capital Audit Report Q4 FY2021

 Concall Invite Q4 FY2022
 Annual Secretarial Compliance Report FY2022
 Newspaper Advertisement for Q4 FY2022 Results
 Certificate under Reg. 40(10) of SEBI (LODR) – FY 2022
 Disclosure of Large Corporate (Apr 2022)
 Reconciliation of Share Capital Audit Report Q4 FY 2022
 Certificate ur. 74(5) – Q4 FY 2022
 Certificate ur. 7(3) - FY 2022
 Further Investment by MMDL in SGTPL (Mar 2022)
 Change in Name of Registrar & Transfer Agent (Mar 2022)
 Schedule of Investor-Analyst Meet (Mar 2022)
 Schedule of Group Investor-Analyst Meet (Mar 2022)
 Inauguration of SOCE in Ahmedabad (Mar 2022)
 Receipt of Import License to Subsidiary - MMDL (Feb 2022)
 Schedule of Investor-Analyst Meet Q3 FY2022
 Determining Materiality of an Event/Info by KMPs(Feb 2022)
 Appointment of Chief Financial Officer (Feb 2022)
 Further Investment by MMDL in SAT (Jan 2022)
 Certificate Under Reg. 74(5) Q3 FY 2022
 Reconciliation of Share Capital Audit Report Q3 FY 2022
 Resignation of Chief Financial Officer (Dec 2021)
 Further investment by MMDL in SGTPL (Dec 2021)
 Schedule of Investor-Analyst Meet (Nov 2021)
 Long Term Credit Rating for Enhanced Rated Amount (Nov 2021)
 Newspaper Advertisement for Q2 FY2022 Results
 Schedule of Investor-Analyst Meet Q2 FY2022
 Reconciliation of Share Capital Audit Report Q2 FY2022
 Upgradation of Credit Rating (Sep 2021)
 Revised Conference Call Invite (Aug 2021)
 Conference Call Invite (Aug 2021)
 Mars Medical Acquires 96% Shares in Shalby Global (Jul 2021)
 Reconciliation of Share Capital Audit Report Q1 FY2022
 Certificate Under Reg. 74(5) (Jun 2021)
 Reg. 30 of SEBl (LODR)- Inaugurated Shalby Zynova (Jun 2021)
 Conference Call Invite & Investor Presentation (May 2021)
 Appointment of Vice Chairman & Global President (May 2021)
 Concall Invite for Audited Financials-Q4 & FY2021 (May 2021)
 Step-down Subsidiary in USA (May 2021)
 Newspaper Publication - Offer for Sale (Apr 2021)
 Disclosure of Large Corporate (Apr 2021)

Financial Year Q1 Q2 Q3 Q4
2017-18
2018-19
2019-20
2020-21
2021-22
2022-23
Financial Year Q1 Q2 Q3 Q4
Board Meeting Intimation News Paper Ad. Intimation News Paper Ad. Intimation News Paper Ad. Intimation News Paper Ad.
2017-18
2018-19
2019-20
2020-21
2021-22
2022-23

 

Share Holder’s Meeting

General Meeting Intimation Book closure / Record date Advertisement Outcome Voting Result
14th AGM – 17-09-2018
15th AGM – 26-08-2019
16th AGM – 14-09-2020
Postal Ballot Notice dated 07-10-2020
17th AGM – 27-09-2021
Postal Ballot Notice dated 26-10-2021
18th AGM – 26-09-2022
Financial Year Q1 Q2 Q3 Q4
2017-18
2018-19
2019-20
2020-21
2021-22
2022-23
RTP HY1 HY2
FY 2018-19
FY 2019-20
FY 2020-21
FY 2021-22

 

  • Dr. Vikram Shah – Chairman & Managing Director, Shalby Limited at Edelweiss India Conference (Feb’18):

 

  • Dr. Vikram Shah – Chairman & Managing Director, Shalby Limited at IIFL Enterprising India IX-2018 (Feb’18):

  • A Special Episode in CNBC Awaaz – Incredible Journey – Rising stars

 

Financial Year Q1 Q2 Q3 Q4
2017-18
2018-19
2019-20
EMERGENCY CONTACT NUMBERS 
Shalby Hospital , SG Highway , Ahmedabad +91 7940203333
Shalby Hospital , Vijay Cross Road , Ahmedabad +91 9924593339
Krishna Shalby Hospital , Ghuma, Ahmedabad +91 9904722345
Shalby Hospital , Naroda , Ahmedabad +91 9913460101
Shalby Hospital , Vapi +91 7046063333
Shalby Hospital , Surat +91 9512660096
Shalby Hospital , Mohali +91 1724907100
Shalby Hospital , Jabalpur +91 9575801020
Shalby Hospital , Indore +91 9174400100
Shalby Hospital , Jaipur +91 7413885999